Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
49.85Price to Sales
VS
Market
Sector
Industry
History
$ 3.56Close
$ 2.35 - $ 6.36 52-Week Range
Ticker Information
Ticker
OBIOCompany Name
ORCHESTRA BIOMED HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQORCHESTRA BIOMED HOLDINGS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
OBIO - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 146.76M | 49.85 | $ 2.94M |
| 3/31/2025 | $ 101.53M | 35.18 | $ 2.89M |
| 12/31/2024 | $ 163.98M | 62.16 | $ 2.64M |
| 9/30/2024 | $ 215.16M | 81.28 | $ 2.65M |
| 6/30/2024 | $ 231.11M | 111.16 | $ 2.08M |
| 3/31/2024 | $ 164.63M | 74.29 | $ 2.22M |
| 12/31/2023 | $ 189.8M | 68.77 | $ 2.76M |
| 9/30/2023 | $ 215.89M | 59.95 | $ 3.6M |
| 6/30/2023 | $ 216.96M | 0 | $ 0 |
| 3/31/2023 | $ 607.84M | 0 | $ 0 |
Key Performance Insights, Last 5 Years
- ORCHESTRA BIOMED HOLDINGS INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, ORCHESTRA BIOMED HOLDINGS INC's average P/S has been 67.83.
- The median P/S for ORCHESTRA BIOMED HOLDINGS INC during this period was 65.46
- ORCHESTRA BIOMED HOLDINGS INC reached its highest P/S over the past 5 years at 111.16.
- The lowest P/S recorded by ORCHESTRA BIOMED HOLDINGS INC in the same timeframe 35.18
ORCHESTRA BIOMED HOLDINGS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for ORCHESTRA BIOMED HOLDINGS INC is calculated as follows: Market Cap [ $ 224.95M ] / Revenues [ $ 0 ]
(=) P/S [ 0 ] OBIO - Price to Sales, Last 5 years
35.18
Minimum
Mar 31, 2025
111.16
Maximum
Jun 30, 2024
67.83
Average
65.46
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.41K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |